Skip to main content

Published locations for Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients

User login

  • Reset your password
  • /content/ibrutinib-associated-decreased-circulating-malignant-cells-and-restored-t-cell-function-cll
  • /fedprac/article/231587/cll/ibrutinib-associated-decreased-circulating-malignant-cells-and-restored-t
  • /hematologynews/article/231587/cll/ibrutinib-associated-decreased-circulating-malignant-cells-and
  • /oncologypractice/article/231587/cll/ibrutinib-associated-decreased-circulating-malignant-cells-and
  • /fedprac/avaho/article/231587/cll/ibrutinib-associated-decreased-circulating-malignant-cells-and
  • /hematology-oncology/article/231587/cll/ibrutinib-associated-decreased-circulating-malignant-cells
  • /b-cell-lymphoma-icymi/article/231587/cll/ibrutinib-associated-decreased-circulating-malignant-cells